$185 Million is the total value of Eversept Partners, LP's 54 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 55.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ZGNX | Buy | ZOGENIX INC | $20,542,621 | -1.2% | 563,429 | +34.4% | 11.12% | +21.9% |
| GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $20,391,894 | +73.6% | 529,484 | +83.0% | 11.04% | +114.2% |
| RCM | Buy | R1 RCM INC | $18,676,983 | +9.1% | 2,349,306 | +39.4% | 10.11% | +34.6% |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $17,194,969 | +6.1% | 1,263,407 | +26.9% | 9.31% | +31.0% |
| SNY | Buy | SANOFIsponsored adr | $13,293,965 | +6.0% | 306,242 | +9.0% | 7.20% | +30.7% |
| RDUS | Buy | RADIUS HEALTH INC | $9,103,354 | -3.3% | 552,053 | +4.4% | 4.93% | +19.3% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $8,403,719 | +13.1% | 232,790 | +92.8% | 4.55% | +39.6% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $6,047,089 | -34.8% | 36,492 | -24.1% | 3.27% | -19.5% |
| DHR | Buy | DANAHER CORP DEL | $4,936,613 | +27.4% | 47,804 | +34.3% | 2.67% | +57.2% |
| ABMD | Buy | ABIOMED INC | $4,530,733 | +194.6% | 13,939 | +307.7% | 2.45% | +263.4% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $4,419,110 | -35.2% | 40,494 | -4.0% | 2.39% | -20.0% |
| MYL | New | MYLAN N Vcall | $4,345,640 | – | 158,600 | +100.0% | 2.35% | – |
| ARGX | Buy | ARGENX SEsponsored adr | $3,672,180 | +105.6% | 38,224 | +62.3% | 1.99% | +153.6% |
| MRK | Sell | MERCK & CO INC | $3,527,912 | -66.6% | 45,800 | -69.0% | 1.91% | -58.8% |
| ENSG | Sell | ENSIGN GROUP INC | $3,323,165 | -35.0% | 85,575 | -36.4% | 1.80% | -19.8% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $3,169,400 | -42.3% | 81,371 | -31.8% | 1.72% | -28.8% |
| TLGT | Buy | TELIGENT INC NEW | $3,079,042 | -63.1% | 2,247,476 | +6.4% | 1.67% | -54.5% |
| TSRO | New | TESARO INC | $2,673,000 | – | 36,000 | +100.0% | 1.45% | – |
| ABT | Sell | ABBOTT LABS | $2,271,162 | -58.8% | 31,400 | -58.2% | 1.23% | -49.1% |
| FATE | New | FATE THERAPEUTICS INC | $2,116,950 | – | 165,000 | +100.0% | 1.15% | – |
| QGEN | New | QIAGEN NV | $1,905,085 | – | 55,300 | +100.0% | 1.03% | – |
| ILMN | New | ILLUMINA INC | $1,544,040 | – | 5,148 | +100.0% | 0.84% | – |
| GHDX | New | GENOMIC HEALTH INC | $1,537,209 | – | 23,866 | +100.0% | 0.83% | – |
| MYL | New | MYLAN N V | $1,507,000 | – | 55,000 | +100.0% | 0.82% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $1,463,003 | – | 69,700 | +100.0% | 0.79% | – |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $1,409,747 | -20.9% | 106,880 | +6.6% | 0.76% | -2.6% |
| LOXO | New | LOXO ONCOLOGY INC | $1,400,700 | – | 10,000 | +100.0% | 0.76% | – |
| BSTC | Buy | BIOSPECIFICS TECHNOLOGIES CO | $1,333,200 | +4.1% | 22,000 | +0.5% | 0.72% | +28.5% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS | $1,323,149 | +16.4% | 163,959 | +10.1% | 0.72% | +43.5% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $1,294,206 | -53.3% | 205,104 | -2.2% | 0.70% | -42.3% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $1,288,371 | +40.3% | 90,412 | +49.7% | 0.70% | +73.2% |
| FOMX | Buy | FOAMIX PHARMACEUTICALS LTD | $1,057,829 | -32.6% | 294,660 | +7.6% | 0.57% | -16.8% |
| AFMD | Sell | AFFIMED N V | $1,044,257 | -44.5% | 335,774 | -22.4% | 0.56% | -31.6% |
| CTRE | CARETRUST REIT INC | $956,199 | +4.1% | 51,264 | 0.0% | 0.52% | +28.5% | |
| ARQL | Buy | ARQULE INC | $954,592 | -41.8% | 344,618 | +19.0% | 0.52% | -28.1% |
| TCDA | Buy | TRICIDA INC | $955,509 | +29.7% | 40,522 | +68.0% | 0.52% | +60.1% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $955,663 | -29.2% | 15,254 | -19.9% | 0.52% | -12.8% |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $860,825 | -13.4% | 42,301 | +95.2% | 0.47% | +6.9% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $792,279 | -87.1% | 8,271 | -81.0% | 0.43% | -84.1% |
| ANTM | ANTHEM INC | $604,049 | -4.2% | 2,300 | 0.0% | 0.33% | +18.1% | |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $601,145 | -37.7% | 62,750 | -21.3% | 0.33% | -22.9% |
| NTRA | New | NATERA INC | $551,964 | – | 39,539 | +100.0% | 0.30% | – |
| CNC | CENTENE CORP DEL | $495,790 | -20.4% | 4,300 | 0.0% | 0.27% | -1.8% | |
| ALBO | ALBIREO PHARMA INC | $442,251 | -25.6% | 18,029 | 0.0% | 0.24% | -8.4% | |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $439,081 | -43.7% | 41,074 | -19.6% | 0.24% | -30.4% |
| FLDM | New | FLUIDIGM CORP DEL | $434,922 | – | 50,455 | +100.0% | 0.24% | – |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $370,646 | -53.6% | 47,096 | -34.7% | 0.20% | -42.7% |
| IVC | Sell | INVACARE CORP | $317,779 | -79.9% | 73,902 | -32.1% | 0.17% | -75.3% |
| SPNE | Sell | SEASPINE HLDGS CORP | $281,972 | -41.4% | 15,459 | -50.0% | 0.15% | -27.5% |
| TGTX | TG THERAPEUTICS INC | $266,500 | -26.8% | 65,000 | 0.0% | 0.14% | -10.0% | |
| OPNT | New | OPIANT PHARMACEUTICALS INC | $200,869 | – | 13,901 | +100.0% | 0.11% | – |
| AQXP | New | AQUINOX PHARMACEUTICALS INC | $159,229 | – | 73,717 | +100.0% | 0.09% | – |
| EPZM | Sell | EPIZYME INC | $156,766 | -68.8% | 25,449 | -46.4% | 0.08% | -61.5% |
| CFMS | Buy | CONFORMIS INC | $48,993 | -63.6% | 136,851 | +7.9% | 0.03% | -54.2% |
| VTL | Exit | VITAL THERAPIES INCput | $0 | – | -38,300 | -100.0% | -0.01% | – |
| AGTC | Exit | APPLIED GENETIC TECHNOL CORP | $0 | – | -14,500 | -100.0% | -0.05% | – |
| MLNT | Exit | MELINTA THERAPEUTICS INC | $0 | – | -26,479 | -100.0% | -0.05% | – |
| FOMX | Exit | FOAMIX PHARMACEUTICALS LTDput | $0 | – | -25,000 | -100.0% | -0.06% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -27,000 | -100.0% | -0.15% | – |
| OPHT | Exit | OPHTHOTECH CORP | $0 | – | -149,100 | -100.0% | -0.15% | – |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -25,000 | -100.0% | -0.19% | – |
| DERM | Exit | DERMIRA INC | $0 | – | -40,018 | -100.0% | -0.19% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -44,140 | -100.0% | -0.22% | – |
| MDCO | Exit | MEDICINES CO | $0 | – | -16,717 | -100.0% | -0.22% | – |
| XRAY | Exit | DENTSPLY SIRONA INC | $0 | – | -16,680 | -100.0% | -0.28% | – |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INCcall | $0 | – | -40,000 | -100.0% | -0.30% | – |
| SGMO | Exit | SANGAMO THERAPEUTICS INCcall | $0 | – | -40,000 | -100.0% | -0.30% | – |
| KIDS | Exit | ORTHOPEDIATRICS CORP | $0 | – | -19,600 | -100.0% | -0.32% | – |
| PODD | Exit | INSULET CORP | $0 | – | -8,765 | -100.0% | -0.41% | – |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INCput | $0 | – | -60,000 | -100.0% | -0.44% | – |
| MODN | Exit | MODEL N INC | $0 | – | -72,283 | -100.0% | -0.50% | – |
| WMGI | Exit | WRIGHT MED GROUP N V | $0 | – | -66,600 | -100.0% | -0.85% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -9,400 | -100.0% | -0.88% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -22,524 | -100.0% | -0.99% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -26,800 | -100.0% | -1.16% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -90,000 | -100.0% | -11.48% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.